New interview from Inderes.
11 Likes
More insider buys, 5,000 shares, Chief Product Officer: Aiforia Technologies Oyj – Johdon liiketoimet – Panu Kauppila - Inderes
23 Likes
Is a campaign underway to signal “hey market, you’re delusional,” or a genuine nose for a good investment spot when the window to buy is briefly open after the earnings report?
5 Likes
Amidst insider buying, an AI solution for prostate cancer diagnostics.
28 Likes
Aiforia’s development platform seems quite efficient, given how these approved algorithms are popping up like mushrooms after rain. Sure, ready-made classified samples are bought for different cancers, but this efficient??
5 Likes
Development time cut by more than half, customer deployment down to a few weeks. We expect accelerating growth, or in the words of NuWays, “hyperscale” years.
From the transcript:
Now we have this Vision Transformer technologies, Foundation Engine engines, all the nice things that we get from a latest technology. We think that we can reduce the development time from 18 months to 8 months. Significant, kind of a reduction on that. It’s a quicker to money on things when we decide to kind of build something and when we can actually commercialize it and, and change it as a revenue to our books. Customer deployment is another thing as well. Sometimes somebody has been questioning, how long time it will take that we deliver. If we look at the current situation, we’ve been using the latest technologies on kind of speeding up those processes, and we can actually deliver less than 4 weeks.
16 Likes
Here are Antti’s comments on Aiforia’s release of a new CE-IVD marked AI solution for prostate cancer diagnostics 
Aiforia announced on Tuesday that it has released a new CE-IVD marked AI solution for prostate cancer diagnostics. The Aiforia® Prostate Cancer Biopsy solution is intended for the analysis of prostate samples. The news follows a similar recently announced tool for gastric cancer diagnostics. The launch of the new model supports our growth forecasts.
16 Likes
Johan Lundin talks about Aiforia’s journey from the start to today, at the University of Helsinki (I think), a week or two ago.
Nothing relevant from an investment perspective, but it was an interesting story overall, and provided many lessons and insights into how bumpy the early stages of building something like this are.
7 Likes